The success of Sildenafil initially sparked a boom for the drug industry, but recent shifts present a uncertain outlook for investors. Lower-cost versions are eroding revenue, and continued litigation add more https://henrimjhu297389.blogacep.com/46803399/sildenafil-and-pharma-a-precarious-bet